Back

The potential role of elevated lipoprotein(a) in the early stages of aortic valve stenosis

31 August 2025 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: Risk factors (5) Biomarkers ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Mr Francisco Sousa

Hospital Central do Funchal, Funchal (Portugal)

7 More presentations in this session

Presentation thumbnail
Association between carotid intima-media thickness and novel lipid parameters in hypertensive patients
Doctor F. Brucato (Milan, IT)
Abstract Slides Video
Presentation thumbnail
Tailoring cardiovascular risk assesment: Vascular ultrasound as an emerging and accesible tool
Doctor A. Velasco (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
Patients with high Calcium Scores and Lipoprotein (a) levels are at the highest risk for cardiovascular events
Doctor D. Sa (Funchal, PT)
Abstract Slides Video
Presentation thumbnail
The importance of Fibrinogen as a cardiovascular risk factor
Doctor A. Rodrigues (Funchal, PT)
Abstract Slides Video
Presentation thumbnail
Nonspecific ventricular repolarization abnormalities: a benign finding or a prognostic concern?
Doctor J. Simoes De Azevedo Massa Pereira (Faro, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Risk factors (5)

The Event

Event poster

ESC Congress 2025

31 August 2025 12:15 CET
You may be interested in
thumbnail
Congress Presentation
Lp(a) and aortic stenosis: epidemiology
thumbnail
Congress Presentation
The effect of the LPA gene on aortic valve calcification in a Portuguese population
thumbnail
Congress Presentation
Lp(a) and aortic stenosis: biological underpinnings

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources